BR0010947A - Composição de somatotropina com seringabilidade aperfeiçoada - Google Patents

Composição de somatotropina com seringabilidade aperfeiçoada

Info

Publication number
BR0010947A
BR0010947A BR0010947-9A BR0010947A BR0010947A BR 0010947 A BR0010947 A BR 0010947A BR 0010947 A BR0010947 A BR 0010947A BR 0010947 A BR0010947 A BR 0010947A
Authority
BR
Brazil
Prior art keywords
improved
syringability
somatotropin
composition
formulation
Prior art date
Application number
BR0010947-9A
Other languages
English (en)
Inventor
Nam Joong Kim
Je Phil Ryoo
Original Assignee
Lg Chem Investment Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chem Investment Ltd filed Critical Lg Chem Investment Ltd
Publication of BR0010947A publication Critical patent/BR0010947A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: "COMPOSIçãO DE SOMATOTROPINA COM SERINGABILIDADE APERFEIçOADA". A presente invenção refere-se a uma composição de somatotropina aperfeiçoada que consiste em somatotropina tendo atividade in vivo, pelo menos uma das vitaminas solúveis em lipídio e pelo menos um dos lubrificantes farmaceuticamente aceitáveis, que aperfeiçoa seringabilidade pobre sob temperatura resfriada que era um defeito da formulação de somatotropina convencional usando-se vitaminas, e que mostra pelo menos o efeito equivalente àquele da formulação convencional.
BR0010947-9A 2000-03-24 2000-10-16 Composição de somatotropina com seringabilidade aperfeiçoada BR0010947A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020000015091A KR100365678B1 (ko) 2000-03-24 2000-03-24 주사능이 개선된 소마토트로핀 조성물
PCT/KR2000/001151 WO2001070256A1 (en) 2000-03-24 2000-10-16 A somatotropin composition with improved syringeability

Publications (1)

Publication Number Publication Date
BR0010947A true BR0010947A (pt) 2002-03-12

Family

ID=19658247

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010947-9A BR0010947A (pt) 2000-03-24 2000-10-16 Composição de somatotropina com seringabilidade aperfeiçoada

Country Status (10)

Country Link
US (1) US6733786B1 (pt)
EP (1) EP1194160A1 (pt)
KR (1) KR100365678B1 (pt)
AU (1) AU783240B2 (pt)
BR (1) BR0010947A (pt)
CA (1) CA2374043C (pt)
EG (1) EG24204A (pt)
MX (1) MXPA01011719A (pt)
WO (1) WO2001070256A1 (pt)
ZA (1) ZA200109364B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100365678B1 (ko) * 2000-03-24 2002-12-26 주식회사 엘지생명과학 주사능이 개선된 소마토트로핀 조성물
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
KR101506925B1 (ko) * 2004-10-01 2015-03-30 램스코르 인코포레이티드 편리하게 이식가능한 서방형 약물 조성물
US8541413B2 (en) 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
AU2009302167B9 (en) * 2008-10-09 2014-05-29 Ramscor, Inc. Composition and method for treating dry eye syndrome

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474980A (en) * 1984-10-04 1995-12-12 Monsanto Company Prolonged release of biologically active somatotropins
GB8724897D0 (en) * 1987-10-23 1987-11-25 Downes S Material
NZ237084A (en) * 1990-02-12 1993-10-26 Lucky Ltd Composition for the prolonged release of somatotropin comprising the somatotropin, a tocopherol component, and an assistant delaying agent
KR0152082B1 (ko) * 1990-12-31 1998-10-15 성재갑 소마토트로핀 조성물
KR940011013A (ko) * 1992-11-27 1994-06-20 최근선 서방성 소마트로핀 제제의 제조방법
KR0177306B1 (ko) * 1996-02-15 1999-03-20 성재갑 소마토트로핀과 비타민의 합제 조성물
DE19641437A1 (de) * 1996-10-08 1998-04-09 Basf Ag 1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung
KR19990071255A (ko) * 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
KR100365678B1 (ko) * 2000-03-24 2002-12-26 주식회사 엘지생명과학 주사능이 개선된 소마토트로핀 조성물

Also Published As

Publication number Publication date
AU7967100A (en) 2001-10-03
EP1194160A1 (en) 2002-04-10
AU783240B2 (en) 2005-10-06
CA2374043C (en) 2011-09-20
EG24204A (en) 2008-10-20
US6733786B1 (en) 2004-05-11
MXPA01011719A (es) 2003-09-10
ZA200109364B (en) 2002-04-01
KR20010089862A (ko) 2001-10-12
KR100365678B1 (ko) 2002-12-26
WO2001070256A1 (en) 2001-09-27
CA2374043A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
BR9808948A (pt) Composição de confeitaria
BR0210056A (pt) composições e métodos para tratamento de hiperplasia
BR0003897A (pt) Aditivo para aumento da resistência à água de formulações cosméticas ou dermatológicas e seus usos
DE69510755D1 (de) Ölsäurereiche Polyolester, diese enthaltende Kompositionen und funktionelle Schmierfluide und Fette
EA200100337A1 (ru) Стабильные жидкие составы ботулинического токсина
BRPI0416292A (pt) composições estabilizadas compreendendo probióticos
CR6306A (es) 1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
BR0213213A (pt) composições farmacêuticas pró-micela
DK1887016T3 (da) Fragmenter af humant choriongonadotropin (HCG) som immunoregulator
BRPI0515316A (pt) compostos de imidazoquinolina
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
DK395689A (da) Pharmaceutisk tilberedning til behandling af diabetes mellitus
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
BR9914631A (pt) Composição imunológica oral indutora de tolerância para prevenção e/ou tratamento de enfermidades e método para prevenção e/ou tratamento de enfermidades
ATE372107T1 (de) Befeuchtungsmittel und dieses enthaltende kosmetika und topische präparate
PT1216041E (pt) Dieta com elevado teor de lipidos
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
BR9809571A (pt) Composição medicinal e processo para produzì-la
BR0010947A (pt) Composição de somatotropina com seringabilidade aperfeiçoada
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
DE69721497D1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
PT984788E (pt) Composicoes farmaceuticas de peptidos com baixa solubilidade em meio fisiologico
ATE356209T1 (de) Mutanten des thyroid-stimulierenden hormons

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time